by European Public Health Alliance | Jul 4, 2016 | Opinion
By Zoltán Massay-Kosubek Policy Co-ordinator for Healthy Trade and Health Equity, EPHA Investment protection rules and their potential reform have become a toxic issue in EU trade policy. Can a fundamentally flawed arbitration system be really reformed? Is addressing...
by European Public Health Alliance | Jul 3, 2016 | Opinion
In June 2016, EPHA attended the Public Health 2016 conference in Toronto which, among many other topics, discussed antimicrobial resistance (AMR) in a satellite symposium. How can AMR be framed as an urgent public health issue that will engage the entire public...
by European Public Health Alliance | Jul 1, 2016 | Opinion
By Yannis Natsis, Policy Coordinator for Universal Access & Affordable Medicines @ynatsis The Netherlands’ Presidency of the European Council proved to be far from quiet in relation to pharmaceutical affairs. June 17 was the concluding Health Ministers Council...
by European Public Health Alliance | Jun 20, 2016 | Opinion
By Sascha Marschang, Policy Manager for Health Systems The Health Council Conclusions on the next steps to combat Antimicrobial Resistance, released on 17 June 2016, urge national governments and the European Commission to collaborate more effectively and coordinate...
by European Public Health Alliance | Jun 16, 2016 | Opinion
Country Specific Recommendations (CSRs) released by the European Commission to Member States this month are part of the streamlined European Semester Process that puts emphasis on a single assessment per Member State, re-focused and fewer CSRs and an earlier...
by European Public Health Alliance | Jun 16, 2016 | Opinion
Could TTIP reverse the progress made by the EU on tobacco control and lead to greater levels of smoking-related diseases and deaths? EPHA’s analysis “Tobacco and Public Health in TTIP’ suggests that TTIP may have a major impact on the consumption of tobacco,...
